Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Financial Post (Toronto, Ontario, Canada)]
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Yahoo! Finance]
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders [Yahoo! Finance]